Biologic approaches to the prevention of sexual transmission of human immunodeficiency virus

Infectious Disease Clinics of North America

Volumn 14, Issue 4, 2000, Pages 983-999

  Blocker, Michael E ^a   Cohen, Myron S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; HEALTH BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; VAGINITIS; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0034488451     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70143-4     Document Type: Article

References (108)

1. Epidemiologic parameters of HIV transmission
2. The ethics of clinical research in the third world
3. UNAIDS/WHO global AIDS statistics
4. Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission
5. HIV-1 infection in an individual homozygous for the CCR5 deletion allele
6. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients
7. Animal studies of prophylaxis
8. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco
9. HIV-1 drug resistance in newly infected individuals
10. Genetic and immunological host factors associated with susceptibility to HIV-1 infection
11. Factors influencing human immunodeficiency virus type 1 transmission by blood transfussion
12. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for disease control and prevention needlestick surveillance group
13. Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society - USA Panel
14. How much do condoms protect against sexually transmitted diseases?
15. Notice to readers: Opening of nonoccupational HIV postexposure prophylaxis registry
16. Public health service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis
17. HIV prevention through early detection and treatment of other sexually transmitted diseases - United States
18. Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy public health service statement
19. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1
20. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
21. Do spermicides containing nonoxynol-9 prevent sexually transmitted diseases?
22. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood
23. HIV-1 in the female genital tract and the effect of antiretroviral therapy
24. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study multicenter AIDS Cohort study, multicenter hemophilia Cohort study, San Francisco City Cohort, ALIVE study
25. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
26. Probability of heterosexual transmission of HIV: Relationship to the number of unprotected sexual contacts. European study group in heterosexual transmission of HIV
27. Female-controlled methods to prevent sexual transmission of HIV
28. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: Implications for transmission
29. Latent infection of CD4. T cells provides a mechanisms for lifelong persistence of HIV-1, even in patients on effective combination therapy
30. The biological phenotype of HIV-1 is usually retained during and after sexual transmission
31. Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina
32. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection
33. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
34. Impact of improved treatment of sexually transmitted disease on HIV infection in rural Tanzania: Randomized control trial
35. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
36. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy
37. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract
38. Postexposure treatment of HIV - Taking some risks for safety's sake
39. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia
40. Preventing HIV infection: Lessons from Mwanza and Rakai
41. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
42. Decreased incidence of sexually transmitted diseases among trucking company workers in Kenya: Results of a behavioral risk reduction programme
43. Anti-HIV type 1 activity of sulfated derivatives of dextrin against primary viral isolates of HIV type 1 in lymphocytes and monocyte-derived macrophages
44. The inhibitory effect of spermicidal agents on replication of HSW-2 and HIV-1 in vitro
45. Failures of zidovudine postexposure prophylaxis
46. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: A randomized controlled trial. Project RESPECT study group
47. Antiretroviral-drug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1
48. The care, of persons with recent sexual exposure to HIV
49. HIV-1-specific mucosal IgA in a cohort of HIV-1 resistant Kenyan sex workers
50. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir
51. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1
52. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes
53. Condom promotion, sexually transmitted disease treatment, and declining incidence of HIV-1 infection in female Zairian sex workers
54. Effect of circumcision on incidence of human immunodeficiency virus type 1 and other sexually transmitted diseases: A prospective cohort study of trucking company employees in Kenya
55. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort
56. Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients
57. Reduced antiretroviral drug susceptibility among patients with primary HIV infection
58. Chemokine receptors: Keys to AIDS pathogenesis?
59. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
60. Vaginal transmission of chimeric simian/human immunodeficiency viruses in Rhesus macaques
61. Postexposure prophylaxis after nonoccupational HIV exposure: Clinical, ethical, and policy considerations
62. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa
63. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy
64. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons
65. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
66. HIV transmission through breastfeeding: A study in Malawi
67. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
68. Male circumcision: Assessment of health benefits and risks
69. Cervical and vaginal shedding of human immunodeficiency, virus type 1-infected cells throughout the menstrual cycle
70. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission
71. High rates of transmission of subtype E human immunodeficiency virus type 1 among heterosexual couples in Northern Thailand: Role of sexually transmitted diseases and immune compromise
72. Changes in sexual behavior and a decline in HIV infection among young men in Thailand
73. Repertoire of chemokine receptor expression in the female genital tract: Implications for human immunodeficiency virus transmission
74. Effects of genital tract inflammation on HIV-1 V3 populations in blood and semen
75. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants
76. Human immunodeficiency virus type 1 strains et subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism
77. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group
78. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases
79. Sexual transmission of HIV: Host factors that shape the epidemic and implications for prevention
80. Attenuated HIV vaccine: Caveats
81. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
82. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
83. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
84. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial. Bangkok collaborative perinatal HIV transmission study group
85. Vaccines for bacterial sexually transmitted infections: A realistic goal?
86. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
87. Evaluation of behavioural interventions in HIV / STI prevention
88. HIV infection and disturbances of vaginal flora during pregnancy
89. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV
90. Effect of zidovudine treatment in late pregnancy on HIV-1 in utero transmission
91. Effectiveness of postinoculation (R)-9-(2-phosphonyl-methoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus (SIV) infection depends critically on timing of initiation and duration of treatment
92. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine
93. Sexual transmission of HIV: Infectiousness and prevention
94. Probability of heterosexual transmission of HIV
95. HIV infection and other STDs: So close and yet so far
96. Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Rakai project study group
97. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomised trial
98. Duration of vaginal retention and potential duration of antiretroviral activity for five nonoxynol-9 containing intravaginal contraceptives
99. The protective effect of condoms and nonoxynol 9 against HIV infection
100. Prevention of intravaginal transmission of SIV infection in rhesus monkeys using PMPA gel [abstract 11246]
101. Transmission of antiretroviral-drug-resistant HIV-1 variants
102. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy
103. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission
104. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection